NON INVASIVE MONITORING SYSTEMS INC /FL/ 10-Q Analysis & Summary – 3/14/2025

⚠️This is not investment advice.

⚠️ This is an experimental project and this report is for informational purposes only and should not be considered investment advice. Conduct your own thorough research and consult with a qualified financial advisor before making any investment decisions. ⚠️

Filing date:

03/14/2025


TLDR:

ELI5:

This company isn’t doing anything right now and is mostly being kept afloat by loans from people connected to the company. It’s unclear if they can stay in business.


Accession #:

0001493152-25-010365

Published on

Analyst Summary

  • General and administrative expenses decreased due to reduced professional fees and insurance premiums.
  • Interest expense on related party notes payable increased, indicating a growing reliance on debt financing from related parties.
  • The company continues to incur net losses, although slightly lower than the previous year.
  • The company has a very small cash balance, highlighting its precarious financial position.
  • Total liabilities have increased significantly due to the increase in notes payable and accrued interest to related parties.
  • The company has a substantial shareholders’ deficit, reflecting years of accumulated losses.
  • Management explicitly states that the company’s financial condition raises substantial doubt about its ability to continue as a going concern.
  • The company’s financing activities are heavily dependent on promissory notes from related parties, raising concerns about potential conflicts of interest.
  • Management has identified material weaknesses in internal control over financial reporting, specifically related to segregation of duties and documentation of internal control procedures.
  • ROA is -553%.
  • ROE is 28.2%.
  • Current Ratio is 0.048.
  • Debt-to-Assets Ratio is 20.63.
  • Interest Coverage Ratio is -2.97.
  • Net Income Growth is 16.2%.
  • EPS Growth is -16.3%.

Opportunities and Risks

  • Opportunity: Potential mergers, acquisitions, or strategic collaborations could provide a path forward.
  • Risk: The company’s status as a shell company with no active operations is a major red flag.
  • Risk: Material weaknesses in internal controls increase the risk of financial misstatements.
  • Risk: Significant reliance on related-party financing raises concerns about potential conflicts of interest and the sustainability of this funding source.
  • Risk: The explicit statement about the company’s going concern uncertainty is a critical red flag.

Potential Implications

Company Performance

  • Continued net losses and reliance on related-party financing will likely hinder the company’s ability to resume operations or pursue strategic alternatives.
  • Material weaknesses in internal controls could lead to financial misstatements and regulatory scrutiny.
  • The going concern uncertainty raises significant doubts about the company’s long-term viability.

Stock Price

  • The company’s precarious financial position and going concern uncertainty are likely to negatively impact its stock price.
  • The lack of operational activity and reliance on related-party financing make the stock highly speculative and risky.
  • Any announcements regarding potential mergers, acquisitions, or strategic collaborations could cause volatility in the stock price.

SEC Filing Report: Non-Invasive Monitoring Systems, Inc. (NIMU) – Form 10-Q for the Period Ended January 31, 2025

Executive Summary

This report analyzes Non-Invasive Monitoring Systems, Inc.’s (NIMU) Form 10-Q for the quarterly period ended January 31, 2025. NIMU is currently a shell company with no active operations. The analysis reveals a continued pattern of net losses, reliance on related-party financing, and a significant accumulated deficit, raising substantial doubt about the company’s ability to continue as a going concern. Furthermore, management has identified material weaknesses in internal controls. Given the lack of operational activity, dependence on related-party funding, and the going concern uncertainty, a “Sell” or “Avoid” recommendation is warranted. The company’s future hinges on its ability to identify and execute a successful merger, acquisition, or strategic collaboration, which is highly uncertain.

Company Overview

Non-Invasive Monitoring Systems, Inc. (NIMU) is a Florida-based company that was previously involved in the development and marketing of whole-body periodic acceleration (WBPA) therapeutic platforms. The company discontinued its operations in May 2019 and is currently classified as a shell company. NIMU is exploring potential mergers, acquisitions, strategic collaborations, and even liquidation. The company’s common stock is traded on the OTC Pink market.

Detailed Analysis

Financial Statement Analysis

The following table summarizes key financial data from the Condensed Consolidated Statements of Operations (in thousands):

Metric Three Months Ended Jan 31, 2025 Three Months Ended Jan 31, 2024 Six Months Ended Jan 31, 2025 Six Months Ended Jan 31, 2024
General and Administrative Expenses $26 $40 $89 $115
Interest Expense – Related Parties $16 $14 $30 $27
Net Loss $(42) $(54) $(119) $(142)

**Key Observations:**

* **Decreasing G&A Expenses:** General and administrative expenses decreased in both the three and six-month periods compared to the previous year, primarily due to reduced professional fees, insurance premiums, and timing of expenses. This is expected given the lack of operations.
* **Increasing Interest Expense:** Interest expense on related party notes payable increased slightly, indicating a growing reliance on debt financing from related parties.
* **Continued Net Losses:** The company continues to incur net losses, although the losses are slightly lower than the previous year. This is unsustainable in the long term without revenue generation.

The following table summarizes key financial data from the Condensed Consolidated Balance Sheets (in thousands):

Metric January 31, 2025 July 31, 2024
Cash $27 $25
Total Assets $43 $34
Total Liabilities $887 $759
Accumulated Deficit $(28,966) $(28,847)
Total Shareholders’ Deficit $(844) $(725)

**Key Observations:**

* **Minimal Cash:** The company has a very small cash balance, highlighting its precarious financial position.
* **Increasing Liabilities:** Total liabilities have increased significantly, primarily due to the increase in notes payable and accrued interest to related parties.
* **Significant Shareholders’ Deficit:** The company has a substantial shareholders’ deficit, reflecting years of accumulated losses.

**Liquidity and Capital Resources:**

The company acknowledges that its cash on hand is insufficient to meet its anticipated cash requirements for the next 12 months. It relies heavily on related-party financing and is exploring other options, including equity offerings, debt financing, and collaborative agreements. However, there is no assurance that such financing will be available.

Management’s Discussion and Analysis (MD&A) Insights

* **Going Concern Uncertainty:** Management explicitly states that the company’s financial condition raises substantial doubt about its ability to continue as a going concern. This is a significant red flag.
* **Focus on Strategic Alternatives:** The MD&A emphasizes the company’s efforts to identify and pursue mergers, acquisitions, strategic collaborations, or liquidation. This indicates a lack of confidence in its ability to revive its previous business.
* **Reliance on Related Parties:** The company’s financing activities are heavily dependent on promissory notes from related parties, particularly Frost Gamma Investments Trust and Dr. Jane Hsiao. This raises concerns about potential conflicts of interest and the sustainability of this funding source.

Red Flags and Uncommon Metrics

* **Shell Company Status:** The company’s status as a shell company with no active operations is a major red flag.
* **Material Weaknesses in Internal Controls:** Management has identified material weaknesses in internal control over financial reporting, specifically related to segregation of duties and documentation of internal control procedures. This increases the risk of financial misstatements.
* **Related Party Transactions:** The significant reliance on related-party financing and the provision of free office space by a related party raise concerns about potential conflicts of interest and the fairness of these transactions.
* **Going Concern Uncertainty:** The explicit statement about the company’s going concern uncertainty is a critical red flag that should not be ignored.

Conclusion and Actionable Insights

NIMU’s Form 10-Q reveals a company in a precarious financial position with no active operations and a heavy reliance on related-party financing. The identified material weaknesses in internal controls and the explicit statement about going concern uncertainty further exacerbate the risks.

**Overall Assessment:**

Given the lack of operational activity, dependence on related-party funding, the going concern uncertainty, and the identified material weaknesses, the outlook for NIMU is highly uncertain.

**Recommendations:**

* **Avoid/Sell:** Investors should avoid investing in NIMU or consider selling their existing holdings. The company’s future is highly uncertain, and the risks outweigh any potential rewards.
* **Monitor for Strategic Developments:** Closely monitor the company’s announcements regarding potential mergers, acquisitions, or strategic collaborations. However, exercise caution and thoroughly evaluate any potential deals before making investment decisions.
* **Assess Related Party Transactions:** Carefully scrutinize any future related-party transactions to ensure they are fair and beneficial to the company and its shareholders.

This analysis is based on the information available in the Form 10-Q and should not be considered investment advice. Investors should conduct their own due diligence and consult with a qualified financial advisor before making any investment decisions.

1. Commentary

Non-Invasive Monitoring Systems Inc. is facing significant financial challenges. The company continues to operate at a loss, with a net loss of $119k for the six months ended January 31, 2025. The company has minimal assets and a substantial accumulated deficit. The company is heavily reliant on related-party financing, which raises concerns about its long-term sustainability.

2. Financial Ratio and Metric Analysis

Profitability

  • Gross Profit Margin: Not Applicable (no revenue)

    • Metric: N/A
  • Operating Profit Margin:

    • Metric: Operating Loss / Revenue. Since there is no revenue, the operating profit margin is not meaningful.
  • Net Profit Margin:

    • Metric: Net Loss / Revenue. Since there is no revenue, the net profit margin is not meaningful.
  • Return on Assets (ROA):

    • Metric: Net Loss (TTM) / Total Assets. To calculate TTM net loss, we will use the net loss for the six months ended January 31, 2025 ($119k) * 2 = $238k. ROA = -$238k / $43k = -5.53 or -553%
  • Return on Equity (ROE):

    • Metric: Net Loss (TTM) / Total Shareholder Equity. ROE = -$238k / (-$844k) = 0.282 or 28.2%
  • Earnings Per Share (EPS) – Basic and Diluted:

    • Metric: Net Loss / Weighted Average Shares Outstanding. For the six months ended January 31, 2025: -$119k / 154,811k shares = -$0.00077 per share. To annualize, -$0.00077 * 2 = -0.00154

Liquidity

  • Current Ratio:

    • Metric: Current Assets / Current Liabilities. $43k / $887k = 0.048
  • Quick Ratio (Acid-Test Ratio):

    • Metric: (Current Assets – Inventory) / Current Liabilities. Since there is no inventory, the quick ratio is the same as the current ratio: $43k / $887k = 0.048
  • Cash Ratio:

    • Metric: Cash / Current Liabilities. $27k / $887k = 0.03

Solvency/Leverage

  • Debt-to-Equity Ratio:

    • Metric: Total Liabilities / Total Shareholder Equity. $887k / (-$844k) = -1.05
  • Debt-to-Assets Ratio:

    • Metric: Total Liabilities / Total Assets. $887k / $43k = 20.63
  • Interest Coverage Ratio (Times Interest Earned):

    • Metric: EBIT / Interest Expense. EBIT is equivalent to operating loss (-$89k). -$89k / $30k = -2.97

Activity/Efficiency

  • Inventory Turnover: Not Applicable (not retail/manufacturing)

    • Metric: N/A
  • Days Sales Outstanding (DSO): Not Applicable (no revenue)

    • Metric: N/A
  • Days Payable Outstanding (DPO):

    • Metric: (Accounts Payable / Operating Costs and Expenses) * Number of Days. ($112k / $89k) * 180 = 226.18 days
  • Asset Turnover:

    • Metric: Revenue / Total Assets. Since there is no revenue, the asset turnover is 0.

Valuation

  • Price-to-Earnings Ratio (P/E):

    • Metric: Share Price / EPS. $0.00 / (-$0.00154) = N/A (undefined)
  • Price-to-Book Ratio (P/B):

    • Metric: Market Cap / Book Value of Equity. Market Cap = Shares Outstanding * Share Price = 154,810,655 * $0.00 = $0. Book Value of Equity = -$844k. P/B = $0 / (-$844k) = 0
  • Price-to-Sales Ratio (P/S):

    • Metric: Market Cap / Revenue. Since there is no revenue, the P/S ratio is 0.
  • Enterprise Value to EBITDA (EV/EBITDA):

    • Metric: Enterprise Value / EBITDA. Enterprise Value = Market Cap + Total Debt – Cash. $0 + $887k – $27k = $860k. EBITDA = Net Income + Interest + Taxes + Depreciation and Amortization. EBITDA = -$119k + $30k + $0 + $0 = -$89k. EV/EBITDA = $860k / (-$89k) = -9.66

Growth Rates

  • Revenue Growth:

    • Metric: (Current Period Revenue – Prior Period Revenue) / Prior Period Revenue. Since there is no revenue, the revenue growth is 0.
  • Net Income Growth:

    • Metric: (Current Period Net Income – Prior Period Net Income) / Prior Period Net Income. (($119k) – ($142k)) / ($142k) = 0.162 or 16.2%
  • EPS Growth:

    • Metric: (Current Period EPS – Prior Period EPS) / Prior Period EPS. ((-$0.00077) – (-$0.00092)) / (-$0.00092) = -0.163 or -16.3%

Other Relevant Metrics

  • Internal Control Weaknesses: The company acknowledges significant deficiencies in its internal controls, including a lack of segregation of duties and formally documented risk assessment processes. This raises serious concerns about the reliability of the financial reporting.
  • Related Party Transactions: The company relies heavily on notes payable from related parties, specifically Frost Gamma Investments Trust and Dr. Jane Hsiao. This dependence on related-party financing could indicate difficulty in obtaining funding from external sources and poses potential conflicts of interest.

⚠️ This is an experimental project and this report is for informational purposes only and should not be considered investment advice. Conduct your own thorough research and consult with a qualified financial advisor before making any investment decisions. ⚠️